腹水超滤浓缩腹腔回输治疗肝硬化顽固性腹水45例临床分析
- 格式:pdf
- 大小:87.46 KB
- 文档页数:1
利用血透装置进行自体腹水浓缩回输治疗肝硬化顽固性腹水【中图分类号】r575【文献标识码】a【文章编号】1672-3783(2011)08-0014-02【摘要】目的:探讨肝硬化顽固性腹水患者腹水浓缩自体回输治疗的疗效。
方法:对48例顽固性腹水患者,进行142次自体腹水超滤浓缩回输腹腔治疗。
结果:腹水超滤前后对腹水电解质无明显影响,治疗后对临床症状改善明显,患者血中白蛋白.总蛋白浓度较治疗前明显增高,差异具有非常显著性(p>0.01),治疗后显效36(75%),有效10(20.8%),无效2例(4.2%)总有效95.8%。
结论:腹水浓缩自体回输术治疗肝硬化顽固性腹水有肯定的疗效,不良反应少,方法简单、易行,并能减轻患者的经济负担,可以在临床上广泛应用。
【关键词】肝硬化顽固性腹水腹水自体回输治疗血透装置how to treat the cirrhosis refractory ascites by the method of ascites concentration of autologous transfusion through hemodialyzerby yang yongzheng【abstract】purpose: in this essay, the curative effect on how to treat the cirrhosis patients who suffer from refractory ascites by the method of ascites concentration of autologous transfusion is mainly discussed. method: 48cirrhosis patients have been treated 142 times by the method of ascites concentration of autologous transfusion. result: there’s no obvious effect on the electrolyte before or after the ultrafiltration of ascites. after the treatment, the clinical symptom of the patients are bettered obviously. the thickness of the albumin, total protein in the patients’blood has been improved a lot after the treatment. the difference is obvious (p>0.01), 36 of the 48 patients’curative effect is obvious ( about 75%), 10 of the 48 patients’curative effect is effective(about 20.8%), and only two patient is no effect(4.2%). in general, about 95.8% of the patients who have been treated by this method is effective. conclusion:the curative effect on how to treat the cirrhosis patients who suffer from refractory ascites by the method of ascites concentration of autologous transfusion is positive and there is a little negative effect. what’s more the method is simple and feasible. and best of all, the patients just pay less money for it. therefore, this method can be generally adopted in clinic.【key words】cirrhosis; refractory ascites;ascites concentration of autologous transfusion; treatment; hemodialyzer.肝硬化腹水是常见病、多发病,经常规治疗无效(利尿.输人白蛋白或血浆等),以往最后多采用放腹水的方法治疗,但此种方法存在易并发肝昏迷,低血压休克、水电解质紊乱、丢失大量蛋白、放腹水完备后腹水增长迅速等副作用。